Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9676721 Compounds and compositions for the inhibition of NAMPT

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 13, 2017

Patent Application Number

13820489

Date Filed

September 2, 2011

Patent Citations Received

US Patent 11939348 Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide

0

US Patent 11878027 Nicotinamide mononucleotide derivatives and their uses

0

US Patent 12076412 Antibody-drug conjugates through specific linker oligopeptides

0

US Patent 11952396 Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use

0

US Patent 11787830 Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use

Patent Primary Examiner

Patent abstract

The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9676721 Compounds and compositions for the inhibition of NAMPT

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool